Routine release testing, ongoing stability, change-control support and post-marketing surveillance analytics for commercial pharmaceutical, consumer healthcare and veterinary products. The work that keeps inspection-ready supply moving.
Routine batch release testing against commercial specification
Annual stability commitments per ICH Q1A
Variations support — analytical evidence for Type IA / IB / II
Change-control supportive analytics (process, supplier, site)
Cleaning verification and shared-line risk monitoring
OOS / OOT investigation with documented root cause
Post-marketing surveillance and complaint sample analysis
Annual Product Quality Review (PQR) supportive analytics
Routine assay, related substances, content uniformity.
Trace-level impurity quantification and complaint-sample investigation.
Residual solvents per ICH Q3C and USP <467>.
Elemental impurities to ICH Q3D for commercial supply.
USP Apparatus 1, 2 with auto-sampling and bracketing.
USP <61>, <62>, <71>, <85> per product class.
Methods, documentation and acceptance criteria are designed to align with the standards below. This describes design intent — formal accreditations are listed on the About page.
Routine release CoA per batch
Annual stability summary reports
Variations data packages (Type IA / IB / II)
OOS / OOT investigation reports with root cause
PQR supportive data tables and trend plots
Inspection-ready raw data and audit trail
Send a short scope and we'll come back with a quote and indicative timeline within one working day.